SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

78,009.25 -70.71
( -0.09%)

Global Indices

Nasdaq

53,757.60 -103.39
(-0.19%)

Dow Jones

7,807.18 -12.81
(-0.16%)

Hang Seng

68,711.00 402.41
(0.59%)

Nikkei 225

10,753.31 -19.36
(-0.18%)

Forex

USD-INR

95.39 0.02
(0.02%)

EUR-INR

109.98 -0.03
(-0.03%)

GBP-INR

128.68 -0.13
(-0.10%)

JPY-INR

0.60 0.00
(-0.03%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

UR Sugar Industries Ltd

Industry : Trading

BSE Code

ISIN Demat

Book Value()

539097

INE904R01027

3.5688762

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

14.18

EPS(TTM)

Face Value()

Div & Yield %

0.09

Back

Titan Biotech consolidated net profit rises 66.17% in the March 2026 quarter

Jun 02,2026

Net profit of Titan Biotech rose 66.17% to Rs 6.73 crore in the quarter ended March 2026 as against Rs 4.05 crore during the previous quarter ended March 2025. Sales rose 38.84% to Rs 48.83 crore in the quarter ended March 2026 as against Rs 35.17 crore during the previous quarter ended March 2025.

For the full year,net profit rose 38.83% to Rs 29.89 crore in the year ended March 2026 as against Rs 21.53 crore during the previous year ended March 2025. Sales rose 31.79% to Rs 206.19 crore in the year ended March 2026 as against Rs 156.45 crore during the previous year ended March 2025.

Particulars	Quarter Ended			Year Ended
	Mar. 2026	Mar. 2025	% Var.	Mar. 2026	Mar. 2025	% Var.
Sales	48.83	35.17	39	206.19	156.45	32
OPM %	19.89	12.99	-	18.72	16.25	-
PBDT	11.58	5.87	97	43.10	28.54	51
PBT	10.28	5.03	104	38.17	24.37	57
NP	6.73	4.05	66	29.89	21.53	39

78,009.25 -70.71 ( -0.09%)

53,757.60 -103.39 (-0.19%)

7,807.18 -12.81 (-0.16%)

68,711.00 402.41 (0.59%)

10,753.31 -19.36 (-0.18%)

95.39 0.02 (0.02%)

109.98 -0.03 (-0.03%)

128.68 -0.13 (-0.10%)

0.60 0.00 (-0.03%)